Resolution of SARS-CoV-2 infection in human lung tissues is driven by extravascular CD163+ monocytes
The lung-resident immune mechanisms driving resolution of SARS-CoV-2 infection in humans remain elusive. Using mice co-engrafted with a genetically matched human immune system and fetal lung xenograft (fLX), we mapped the immunological events defining resolution of SARS-CoV-2 infection in human lung tissues. Viral infection is rapidly cleared from fLX following a peak of viral replication. Acute replication results in the emergence of cell subsets enriched in viral RNA, including extravascular inflammatory monocytes (iMO) and macrophage-like T-cells, which dissipate upon infection resolution. iMO display robust antiviral responses, are transcriptomically unique among myeloid lineages, and their emergence associates with the recruitment of circulating CD4+ monocytes. Consistently, mice depleted for human CD4+ cells but not CD3+ T-cells failed to robustly clear infectious viruses and displayed signatures of chronic infection. Our findings uncover the transient differentiation of extravascular iMO from CD4+ monocytes as a major hallmark of SARS-CoV-2 infection resolution and open avenues for unravelling viral and host adaptations defining persistently active SARS-CoV-2 infection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
bioRxiv : the preprint server for biology - (2024) vom: 08. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kenney, Devin [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 21.03.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1101/2024.03.08.583965 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36986154X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36986154X | ||
003 | DE-627 | ||
005 | 20240322000624.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240318s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2024.03.08.583965 |2 doi | |
028 | 5 | 2 | |a pubmed24n1339.xml |
035 | |a (DE-627)NLM36986154X | ||
035 | |a (NLM)38496468 | ||
035 | |a (PII)2024.03.08.583965 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kenney, Devin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Resolution of SARS-CoV-2 infection in human lung tissues is driven by extravascular CD163+ monocytes |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 21.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a The lung-resident immune mechanisms driving resolution of SARS-CoV-2 infection in humans remain elusive. Using mice co-engrafted with a genetically matched human immune system and fetal lung xenograft (fLX), we mapped the immunological events defining resolution of SARS-CoV-2 infection in human lung tissues. Viral infection is rapidly cleared from fLX following a peak of viral replication. Acute replication results in the emergence of cell subsets enriched in viral RNA, including extravascular inflammatory monocytes (iMO) and macrophage-like T-cells, which dissipate upon infection resolution. iMO display robust antiviral responses, are transcriptomically unique among myeloid lineages, and their emergence associates with the recruitment of circulating CD4+ monocytes. Consistently, mice depleted for human CD4+ cells but not CD3+ T-cells failed to robustly clear infectious viruses and displayed signatures of chronic infection. Our findings uncover the transient differentiation of extravascular iMO from CD4+ monocytes as a major hallmark of SARS-CoV-2 infection resolution and open avenues for unravelling viral and host adaptations defining persistently active SARS-CoV-2 infection | ||
650 | 4 | |a Preprint | |
700 | 1 | |a O'Connell, Aoife K |e verfasserin |4 aut | |
700 | 1 | |a Tseng, Anna E |e verfasserin |4 aut | |
700 | 1 | |a Turcinovic, Jacquelyn |e verfasserin |4 aut | |
700 | 1 | |a Sheehan, Meagan L |e verfasserin |4 aut | |
700 | 1 | |a Nitido, Adam D |e verfasserin |4 aut | |
700 | 1 | |a Montanaro, Paige |e verfasserin |4 aut | |
700 | 1 | |a Gertje, Hans P |e verfasserin |4 aut | |
700 | 1 | |a Ericsson, Maria |e verfasserin |4 aut | |
700 | 1 | |a Connor, John H |e verfasserin |4 aut | |
700 | 1 | |a Vrbanac, Vladimir |e verfasserin |4 aut | |
700 | 1 | |a Crossland, Nicholas A |e verfasserin |4 aut | |
700 | 1 | |a Harly, Christelle |e verfasserin |4 aut | |
700 | 1 | |a Balazs, Alejandro B |e verfasserin |4 aut | |
700 | 1 | |a Douam, Florian |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t bioRxiv : the preprint server for biology |d 2020 |g (2024) vom: 08. März |w (DE-627)NLM31090014X |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:08 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2024.03.08.583965 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 08 |c 03 |